Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
System messages
  • Session was invalidated!

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Introduction and aim. Cardiovascular diseases remains the leading cause of death in most of devoloped societies, including Poland. The study aimed to assess the changes in the number, duration, and costs of hospitalizations due to myocardial infarction in Silesian voivodeship (Poland) in 2009-2014. Material and methods. Data were obtained from the Silesian Voivodeship Branch of the National Health Fund. The number, costs, and duration of healthcare services granted during an inpatient hospital stay to patients with acute initial or subsequent myocardial infarction in 2009-2014 were processed and analyzed quarterly for the whole Silesian voivodeship and its subregions. Results. From 54826 patients aged 66±12, the majority were males (62.3%) and 63.4% of 80866 hospitalizations were granted to them. We observed a decreasing trend for the total number of healthcare services granted in 2009-2014 that varied depending on the subregion. Simultaneously, we found that in most subregions the costs of services and the number of invasive services increased over time. We observed that treating patients above 80 years with acute initial or subsequent myocardial infarction generated lower costs of hospitalization but was extended in time. Conclusion. Increased number and costs and accompanying reduced duration of hospitalizations granted in 2009-2014, especially in the range of invasive cardiology and cardiac surgery, results from implementing international guidelines and recommendations for acute myocardial infarction procedures. Lower cost and extended time of hospitalization for patients older than 80 years most likely result from using conservative (non-invasive) methods of treatment.
EN
ObjectivesAccording to the Organization for Economic Cooperation and Development (OECD) data, 13% of deaths recorded in the European Union in 2010 were related to coronary heart disease. The Polish Central Statistical Office data show that cardiovascular mortality in 2014 was at the level of 100.1/100 000 general population. The aim of the study was to assess the current burden of deaths due to acute myocardial infarction (AMI) with the assessment of temporal and spatial variability in the Silesian Voivodeship, Poland.Material and MethodsDepersonalized data obtained from the Silesian Voivodeship Branch of the National Health Fund of Poland, based in Katowice, were used as the study material. The death rate due to acute or subsequent myocardial infarction in each of the subregions of the Silesian Voivodeship was standardized to the European Standard Population 2013. The analyses of the annual AMI death rate for 2009–2014 were performed and assigned to all the subregions of the Silesian Voivodeship, according to the patients’ domicile. ResultsIn this study, 37.7% of the patients (N = 20 806) were females, and 30 142 healthcare services were granted to them, accounting for 36.64% of all services provided to all patients. The average patient’s age during the service provision was 66±12 years, with women being about 6.5 years older than men (70±12 years vs. 64±11 years, respectively). The standardized death rate (SDR) values in each of the 8 subregions of the Silesian Voivodeship were analyzed. In 2009–2014, a substantial decrease in the SDR was noted in 7 of them, except for the Sosnowiec subregion in which an increase in the average annual SDR value was observed. Moreover, its values were the highest in the whole Silesian Voivodeship.ConclusionsThe obtained results confirmed the spatial variability of mortality due to AMI in the study region. The worst situation was observed in the Sosnowiec subregion in which the number of specific deaths continuously increased, probably due to the limited availability of cardiological and invasive cardiology treatments or adverse health conditions.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.